Inside the murky new AI chip economy - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号):
请您阅读我们的用户注册协议隐私权保护政策,点击下方按钮即视为您接受。
英伟达

Inside the murky new AI chip economy

The growth of loans secured by Nvidia’s GPUs is a note for caution

Financial history is littered with weird and wonderful examples of collateral. In the 19th century, for instance, Peru used its future earnings from guano — a substance made from bat, bird and seal droppings — to secure loans for large-scale projects. The pooey mixture was an effective fertiliser, and readily available in the nearby Chincha Islands. Today, securities are thankfully less pungent, though not necessarily less toxic. Dodgy mortgage-backed securities helped trigger the 2008 financial crisis. What, then, to make of the latest financial innovation: collateralised artificial intelligence chips?

The Financial Times has reported that Wall Street’s largest financial institutions had loaned more than $11bn to “neocloud” groups, backed by their possession of Nvidia’s AI chips. These companies include names such as CoreWeave, Crusoe and Lambda, and provide cloud computing services to tech businesses building AI products. They have acquired tens of thousands of Nvidia’s graphics processing units (GPUs) through partnerships with the chipmaker. And with capital expenditure on data centres surging, in the rush to develop AI models, the company’s chips have become a precious commodity.

Euphoria over new technologies often goes hand in hand with financial innovation, which also reinforces it. Two centuries ago, during the railway boom in America and Britain, some railroad companies secured loans to lay more tracks, backed in part by their existing routes. Neoclouds are emulating them today. They provide data storage infrastructure for AI developers via power-purchase agreements. The loans they obtain from the likes of Blackstone, Pimco, Carlyle and BlackRock, secured by Nvidia chips, then allow them to buy more chips. In the event of a default, the lenders would acquire their chips and leasing contracts.

The rapid growth of a new debt market in a still nascent industry requires a note for caution. First, chips are unlikely to hold their collateral value over the long-term. Although GPU demand remains high, supply has risen as hardware reserves have been resold and could rise even further when leasing contracts expire. New chips developed by Nvidia, or its wannabe competitors, which include Microsoft, Google and Amazon, could also undermine the value of existing collateral.

Second, the deals may stretch valuations in the sector. The precise details of the arrangements between Nvidia and the neoclouds are unclear. But the chipmaker is itself an investor in some of the start-ups, which are in turn among its largest customers. Armed with Nvidia chips to secure loans, the cloud providers can then use the capital to buy more chips from Nvidia. This dynamic could inflate Nvidia’s earnings, and means the neocloud groups risk becoming highly leveraged, too. Third, the tie-ups with cloud providers could allow Nvidia to maintain the dominance of its chips, which adds to market concentration risks.

The chips-for-security trend is still young, and based on current lending volumes Wall Street’s largest financiers are perhaps not too concerned about their exposure just yet. But the development does shine a light on some risky lending, circular financing and competition dynamics that are propping up the AI boom. Investors ought to be wary of the potential pitfalls. Nvidia may be wise to draw clearer lines between its commercial and venture interests, which would support market transparency.

Financial innovation is often positive, and done well, it can channel capital to growth-enhancing projects. But as billions of dollars continue to flow into AI infrastructure, the pressure on developers to generate revenue is mounting. If risky and opaque financial engineering continues to feed the frenzy, prices risk moving further from reality. In that case, the deeper and wider any pain will be should there be a correction.

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

凯勒拉治疗学公司在生物技术领域创纪录的IPO中融资6.25亿美元

最新的生物科技公司首次公开募股创下历史新高。
11小时前

Rivian向大型汽车制造商推介软件合作

Rivian首席执行官表示,如果没有更好的软件,传统车企不可能维持其市场份额。

Mythos网络安全风波,预示AI将进入稀缺经济时代

随着前沿模型不断进化,谁能拿到这项技术,可能会变得至关重要。

日本医生警告:伊朗战争将威胁医疗物资供应

首相高市早苗下令释放手套储备,全亚洲忧虑加剧

特朗普能否将鲍威尔从美联储主席之位拉下马?

特朗普表示,如果他提名的继任者沃什在5月15日前未获确认,他将寻求解雇现任主席鲍威尔。

北约与欧盟就防务支出爆发“地盘之争”

这场争议的核心在于,欧盟资金是否应用于采购美国武器。
设置字号×
最小
较小
默认
较大
最大
分享×